Literature DB >> 20876535

InsP3R-associated cGMP kinase substrate determines inositol 1,4,5-trisphosphate receptor susceptibility to phosphoregulation by cyclic nucleotide-dependent kinases.

Wataru Masuda1, Matthew J Betzenhauser, David I Yule.   

Abstract

Ca(2+) release through inositol 1,4,5-trisphosphate receptors (InsP(3)R) can be modulated by numerous factors, including input from other signal transduction cascades. These events shape the spatio-temporal characteristics of the Ca(2+) signal and provide fidelity essential for the appropriate activation of effectors. In this study, we investigate the regulation of Ca(2+) release via InsP(3)R following activation of cyclic nucleotide-dependent kinases in the presence and absence of expression of a binding partner InsP(3)R-associated cGMP kinase substrate (IRAG). cGMP-dependent kinase (PKG) phosphorylation of only the S2+ InsP(3)R-1 subtype resulted in enhanced Ca(2+) release in the absence of IRAG expression. In contrast, IRAG bound to each InsP(3)R subtype, and phosphorylation of IRAG by PKG attenuated Ca(2+) release through all InsP(3)R subtypes. Surprisingly, simply the expression of IRAG attenuated phosphorylation and inhibited the enhanced Ca(2+) release through InsP(3)R-1 following cAMP-dependent protein kinase (PKA) activation. In contrast, IRAG expression did not influence the PKA-enhanced activity of the InsP(3)R-2. Phosphorylation of IRAG resulted in reduced Ca(2+) release through all InsP(3)R subtypes during concurrent activation of PKA and PKG, indicating that IRAG modulation is dominant under these conditions. These studies yield mechanistic insight into how cells with various complements of proteins integrate and prioritize signals from ubiquitous signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876535      PMCID: PMC2988395          DOI: 10.1074/jbc.M110.168989

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  The contribution of serine residues 1588 and 1755 to phosphorylation of the type I inositol 1,4,5-trisphosphate receptor by PKA and PKG.

Authors:  Matthew D Soulsby; Kamil Alzayady; Qun Xu; Richard J H Wojcikiewicz
Journal:  FEBS Lett       Date:  2004-01-16       Impact factor: 4.124

2.  Functional osteoclast attachment requires inositol-1,4,5-trisphosphate receptor-associated cGMP-dependent kinase substrate.

Authors:  Beatrice B Yaroslavskiy; Irina Turkova; Yujuan Wang; Lisa J Robinson; Harry C Blair
Journal:  Lab Invest       Date:  2010-06-21       Impact factor: 5.662

3.  Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta.

Authors:  J Schlossmann; A Ammendola; K Ashman; X Zong; A Huber; G Neubauer; G X Wang; H D Allescher; M Korth; M Wilm; F Hofmann; P Ruth
Journal:  Nature       Date:  2000-03-09       Impact factor: 49.962

4.  Functional properties of recombinant type I and type III inositol 1, 4,5-trisphosphate receptor isoforms expressed in COS-7 cells.

Authors:  D Boehning; S K Joseph
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

5.  IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase.

Authors:  Angela Geiselhöringer; Matthias Werner; Katja Sigl; Petra Smital; René Wörner; Linda Acheo; Juliane Stieber; Pascal Weinmeister; Robert Feil; Susanne Feil; Jörg Wegener; Franz Hofmann; Jens Schlossmann
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

6.  Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha.

Authors:  Tie-Shan Tang; Huiping Tu; Zhengnan Wang; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

7.  Distribution of IRAG and cGKI-isoforms in murine tissues.

Authors:  A Geiselhöringer; M Gaisa; F Hofmann; J Schlossmann
Journal:  FEBS Lett       Date:  2004-09-24       Impact factor: 4.124

8.  Phosphorylation of type-1 inositol 1,4,5-trisphosphate receptors by cyclic nucleotide-dependent protein kinases: a mutational analysis of the functionally important sites in the S2+ and S2- splice variants.

Authors:  Larry E Wagner; Wen-Hong Li; David I Yule
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

Review 9.  Inositol 1,4,5-trisphosphate receptors as signal integrators.

Authors:  Randen L Patterson; Darren Boehning; Solomon H Snyder
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

10.  Functional consequences of phosphomimetic mutations at key cAMP-dependent protein kinase phosphorylation sites in the type 1 inositol 1,4,5-trisphosphate receptor.

Authors:  Larry E Wagner; Wen-Hong Li; Suresh K Joseph; David I Yule
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

View more
  10 in total

1.  Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs.

Authors:  Rahul Chandrasekhar; Kamil J Alzayady; Larry E Wagner; David I Yule
Journal:  J Biol Chem       Date:  2016-01-11       Impact factor: 5.157

2.  Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.

Authors:  Kamil J Alzayady; Larry E Wagner; Rahul Chandrasekhar; Alina Monteagudo; Ronald Godiska; Gregory G Tall; Suresh K Joseph; David I Yule
Journal:  J Biol Chem       Date:  2013-08-16       Impact factor: 5.157

3.  Activation of cyclic GMP-dependent protein kinase blocks alcohol-mediated cell death and calcium disruption in cerebellar granule neurons.

Authors:  Dimitrios E Kouzoukas; Ramesh C Bhalla; Nicholas J Pantazis
Journal:  Neurosci Lett       Date:  2018-04-19       Impact factor: 3.046

4.  Jaw1/LRMP increases Ca2+ influx upon GPCR stimulation with heterogeneous effect on the activity of each ITPR subtype.

Authors:  Wataru Okumura; Takuma Kozono; Hiroyuki Sato; Hitomi Matsui; Tsubasa Takagi; Takashi Tonozuka; Atsushi Nishikawa
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

5.  Antiplatelet activity of nifedipine is mediated by inhibition of NF-κB activation caused by enhancement of PPAR-β/-γ activity.

Authors:  Ching-Yu Shih; I-Hsin Lin; James-Cheng Ding; Fu-Chi Chen; Tz-Chong Chou
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 6.  Regulation of IP3 receptors by cyclic AMP.

Authors:  Colin W Taylor
Journal:  Cell Calcium       Date:  2016-11-06       Impact factor: 6.817

7.  Cyclic AMP Recruits a Discrete Intracellular Ca2+ Store by Unmasking Hypersensitive IP3 Receptors.

Authors:  Vera Konieczny; Stephen C Tovey; Stefania Mataragka; David L Prole; Colin W Taylor
Journal:  Cell Rep       Date:  2017-01-17       Impact factor: 9.423

8.  Inhibitory Neural Regulation of the Ca 2+ Transients in Intramuscular Interstitial Cells of Cajal in the Small Intestine.

Authors:  Salah A Baker; Bernard T Drumm; Caroline A Cobine; Kathleen D Keef; Kenton M Sanders
Journal:  Front Physiol       Date:  2018-04-09       Impact factor: 4.566

9.  Prostaglandin E2 Inhibits Histamine-Evoked Ca2+ Release in Human Aortic Smooth Muscle Cells through Hyperactive cAMP Signaling Junctions and Protein Kinase A.

Authors:  Emily J A Taylor; Evangelia Pantazaka; Kathryn L Shelley; Colin W Taylor
Journal:  Mol Pharmacol       Date:  2017-09-06       Impact factor: 4.436

10.  Acetylcholine promotes Ca2+ and NO-oscillations in adipocytes implicating Ca2+→NO→cGMP→cADP-ribose→Ca2+ positive feedback loop--modulatory effects of norepinephrine and atrial natriuretic peptide.

Authors:  Egor A Turovsky; Mariya V Turovskaya; Ludmila P Dolgacheva; Valery P Zinchenko; Vladimir V Dynnik
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.